July 31 (Reuters) - Cannabis company Cresco Labs said on Monday it has terminated the $2 billion deal to buy rival Columbia Care Inc. (Reporting by Arshreet Singh in Bengaluru; Editing by Krishna Chandra Eluri)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 CAD | +0.47% | -1.83% | +20.11% |
05-16 | Cresco Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : Cresco Labs Inc., Q1 2024 Earnings Call, May 15, 2024 |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,644 JPY | +2.72% | +7.87% | 332M | ||
2.15 CAD | +0.47% | -1.83% | 551M | ||
0.24 CAD | -7.69% | -5.88% | 83.6M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.11% | 551M | |
+55.19% | 815B | |
+45.71% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.60% | 247B | |
+3.93% | 229B | |
+13.99% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- CL Stock
- News Cresco Labs Inc.
- Cresco Labs terminates $2 bln deal to buy Columbia Care